Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rivera

Showing results (601-610 of 631) with videos related to

Pageof 64
Sort By:
Annals of the Rheumatic Diseases|April 24, 2026
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritisAbhimanyu Amarnani, Cristobal F Rivera, Macintosh Cornwell, et al.
American Journal of Nephrology|May 22, 2013
Mycophenolate as maintenance therapy for lupus nephritis with impaired renal functionF Rivera, M L Illescas, E López-Rubio, et al.
Nanoscale|July 18, 2017
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanomaR Calderon-Gonzalez, H Terán-Navarro, I García, et al.
American Journal of Nephrology|April 21, 2012
Mycophenolate as induction therapy in lupus nephritis with renal function impairmentF Rivera, X Fulladosa, R Poveda, et al.
BMC Biology|January 25, 2024
A high-performance computational workflow to accelerate GATK SNP detection across a 25-genome datasetYong Zhou, Nagarajan Kathiresan, Zhichao Yu, et al.
Nature Methods|May 1, 2025
ATLAS: a rationally designed anterograde transsynaptic tracerJacqueline F Rivera, Haoyang Huang, Weiguang Weng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2017
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trialA Abad, E Martínez-Balibrea, J M Viéitez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ Y Douillard, S Siena, J Cassidy, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 24, 2025
Suction tube uterine tamponade versus uterine balloon tamponade for treatment of refractory postpartum hemorrhage: A randomized clinical feasibility trialMandisa Singata-Madliki, Albaro J Nieto-Calvache, Luisa F Rivera Torres, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2014
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02F Rivera, B Massutí, M Salcedo, et al.
Pageof 64

Showing results (601-610 of 631) with videos related to

Sort By:
Pageof 64
Annals of the Rheumatic Diseases|April 24, 2026
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritisAbhimanyu Amarnani, Cristobal F Rivera, Macintosh Cornwell, et al.
American Journal of Nephrology|May 22, 2013
Mycophenolate as maintenance therapy for lupus nephritis with impaired renal functionF Rivera, M L Illescas, E López-Rubio, et al.
Nanoscale|July 18, 2017
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanomaR Calderon-Gonzalez, H Terán-Navarro, I García, et al.
American Journal of Nephrology|April 21, 2012
Mycophenolate as induction therapy in lupus nephritis with renal function impairmentF Rivera, X Fulladosa, R Poveda, et al.
BMC Biology|January 25, 2024
A high-performance computational workflow to accelerate GATK SNP detection across a 25-genome datasetYong Zhou, Nagarajan Kathiresan, Zhichao Yu, et al.
Nature Methods|May 1, 2025
ATLAS: a rationally designed anterograde transsynaptic tracerJacqueline F Rivera, Haoyang Huang, Weiguang Weng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2017
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trialA Abad, E Martínez-Balibrea, J M Viéitez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ Y Douillard, S Siena, J Cassidy, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 24, 2025
Suction tube uterine tamponade versus uterine balloon tamponade for treatment of refractory postpartum hemorrhage: A randomized clinical feasibility trialMandisa Singata-Madliki, Albaro J Nieto-Calvache, Luisa F Rivera Torres, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2014
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02F Rivera, B Massutí, M Salcedo, et al.
Pageof 64